Project description DEENESFRITPL New platform for connected medical devices Diagnostics and medical devices manufacturers are going through a digital transformation. Recent technological advancements are increasing the speed and accuracy of diagnosis, which can help reduce the time it takes to treat a patient. The Internet of Medical Things (IoMT) – a combination of medical devices and applications that can connect to healthcare information technology systems – is revolutionising healthcare. This is why medical device companies need to transform into data companies. The EU-funded bio-T project is developing a special platform for connected medical devices to reduce risk and save valuable time and money. It is a flexible, secure and cloud-agnostic software solution allowing quick and affordable device connectivity. Show the project objective Hide the project objective Objective The Internet of Medical things (IoMT), a multi hundred billion Euro market by 2028, presents an opportunity to revolutionize healthcare by collecting and analysing real time patient data. The IoMT brings together the digital and physical worlds to improve the speed and accuracy of diagnosis and treatments, and monitor and modify patient behaviour and health status in real time. It improves health care organisations’ operational productivity and effectiveness by streamlining clinical processes, information and work flows. Therefore medical device companies need to transform into data companies. BUT IoMT is inherently complex, and vendors face Major skill and technology gaps they must overcome in areas such as cyber security, Data Privacy and Quality regulations as well as scaling IoMT solutions to support Millions of devices worldwide. The bio-T™ platform is HIPAA & GDPR compliant, designed specifically for connected medical devices with the aim of reducing risk and saving valuable time, money and focus for healthcare innovators. The bio-T™ platform is an IoMT specific solution built to be flexible, secure, and cloud-agnostic, saving innovators the need to “reinvent the wheel” for their own device. Designed to provide complete flexibility and data ownership, the bio-T™ platform is a software allowing quick and affordable device connectivity and healthcare-related functions, including adherence management, remote patient monitoring, regulation compliance (US FDA & HIPAA, EU ISO & GDPR), and verification and validation protocols. bio-T is home for expert IoT, cloud and mobile app engineers, and has years of experience developing outstanding solutions for connected healthcare products. The IoMT market is expected to grow at a compound annual growth rate (CAGR) of 30.8 per cent, from €37 billion in 2017 to €158 billion by 2022. The tens of thousands of companies worldwide represent a €9b market size for bio-T. Fields of science medical and health scienceshealth scienceshealth care serviceseHealthnatural sciencescomputer and information sciencesinternetinternet of thingssocial scienceseconomics and businessbusiness and managementinnovation managementsocial scienceseconomics and businessbusiness and managementbusiness modelsnatural sciencescomputer and information sciencescomputer security Programme(s) H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme H2020-EU.3. - PRIORITY 'Societal challenges H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies Topic(s) EIC-SMEInst-2018-2020 - SME instrument Call for proposal H2020-EIC-SMEInst-2018-2020 See other projects for this call Sub call H2020-SMEInst-2018-2020-1 Funding Scheme SME-1 - SME instrument phase 1 Coordinator SOFTIMIZE LTD Net EU contribution € 50 000,00 Address 2 granit st 4951446 Petach tikva Israel See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 21 429,00
